These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18350269)

  • 41. Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulin.
    Vanhorebeek I; Langouche L
    Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):449-59. PubMed ID: 20108584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does glycemic control with insulin therapy play a role for critically ill patients in hospital?
    Patel AH; Pittas AG
    CMAJ; 2006 Mar; 174(7):917-8. PubMed ID: 16567751
    [No Abstract]   [Full Text] [Related]  

  • 43. Glycaemic control in paediatric critical care.
    Preissig C; Rigby M
    Lancet; 2009 Apr; 373(9673):1423; author reply 1424. PubMed ID: 19394525
    [No Abstract]   [Full Text] [Related]  

  • 44. Glycaemic control in paediatric critical care.
    Zuurbier CJ; Bos AP; van Wezel HB
    Lancet; 2009 Apr; 373(9673):1423; author reply 1424. PubMed ID: 19394524
    [No Abstract]   [Full Text] [Related]  

  • 45. Safe utilization of hyperglycemia management in the ICU.
    Loh-Trivedi M; Croley WC
    Curr Drug Saf; 2010 Jan; 5(1):19-21. PubMed ID: 20210715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycemic control and insulin therapy in sepsis and critical illness.
    Garcia Branco R; Tasker RC; Ramos Garcia PC; Piva JP; Dias Xavier L
    J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S128-36. PubMed ID: 18038018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restoring normoglycaemia: not so harmless.
    Preiser JC
    Crit Care; 2008; 12(1):116. PubMed ID: 18341709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensive insulin management of inpatient hyperglycemia: where are we?
    Molitch ME
    J Hosp Med; 2010 Oct; 5(8):429-31. PubMed ID: 20945467
    [No Abstract]   [Full Text] [Related]  

  • 49. Glycaemic control in paediatric critical care.
    Joosten K; Verbruggen SC; Verhoeven JJ
    Lancet; 2009 Apr; 373(9673):1423-4; author reply 1424. PubMed ID: 19394523
    [No Abstract]   [Full Text] [Related]  

  • 50. Glucose control in critically ill patients.
    Van den Berghe G; Bouillon R; Mesotten D
    N Engl J Med; 2009 Jul; 361(1):89; author reply 91-2. PubMed ID: 19571290
    [No Abstract]   [Full Text] [Related]  

  • 51. Intravenous insulin nomogram improves blood glucose control in the critically ill.
    Brown G; Dodek P
    Crit Care Med; 2001 Sep; 29(9):1714-9. PubMed ID: 11546970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should glucocorticoid-induced hyperglycemia be treated in patients with septic shock?
    Van den Berghe G
    JAMA; 2010 Jan; 303(4):365-6. PubMed ID: 20103763
    [No Abstract]   [Full Text] [Related]  

  • 53. Blood glucose control in critically ill adults and children: a survey on stated practice.
    Hirshberg E; Lacroix J; Sward K; Willson D; Morris AH
    Chest; 2008 Jun; 133(6):1328-1335. PubMed ID: 18339779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes.
    Schultz MJ; Wolthuis EK; Moeniralam HS; Levi M
    J Crit Care; 2005 Sep; 20(3):199-204. PubMed ID: 16253786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia.
    Dandona P; Aljada A; Bandyopadhyay A
    Diabetes Care; 2003 Feb; 26(2):516-9. PubMed ID: 12547892
    [No Abstract]   [Full Text] [Related]  

  • 56. Tight glycaemic control using soluble insulin benefits critically ill patients during hospitalisation.
    Cardiovasc J S Afr; 2006; 17(4):218. PubMed ID: 17001433
    [No Abstract]   [Full Text] [Related]  

  • 57. Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
    Krinsley JS
    Hosp Pract (1995); 2015; 43(3):191-7. PubMed ID: 26224425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy and safety of glucose control algorithms in intensive care: a pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial.
    Henderson WR; Dhingra V; Chittock D; Foster D; Hebert P; Cook D; Heyland D; Dodek P; Griesdale D; Schulzer M; Ronco JJ;
    Pol Arch Med Wewn; 2009; 119(7-8):439-46. PubMed ID: 19776683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intensive insulin therapy in critically ill patients--pro].
    Ellger B
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2480. PubMed ID: 17066359
    [No Abstract]   [Full Text] [Related]  

  • 60. Insulin: a wonder drug in the critically ill?
    Johan Groeneveld AB; Beishuizen A; Visser FC
    Crit Care; 2002 Apr; 6(2):102-5. PubMed ID: 11983030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.